Medication info
Namerin Tablets (Nabumetone)

Namerin Tablets (Nabumetone)

Prescription medicationTabletOral
Ingredient · strength
Nabumetone›500mg / 1 tablet
Manufacturer / importer
Jungheon Pharmaceutical Co., Ltd.
Appearance
Yellow oval film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 200611329 · Notified 2006.12.12 · Insurance code 053300040

Summary

Main use
Relief of pain and inflammation associated with arthritis
Who takes it
Adults · Children
Adult dose
This drug is for oral use. Swallow without chewing (tablets only). ○ Adults : Administer nabumetone 1 g orally once daily at bedtime. If symptoms are severe or persistent, or worsen rapidly, administer an additional 500 mg∼1 g orally in the morning. ○ Elderly patients : As with many other drugs, plasma concentrations may be higher in elderly patients. Do not exceed a maximum of 1 g daily; in some cases, 500 mg may provide satisfactory symptom relief.
Child dose
○ Children : Clinical data on the use of this preparation in children are not yet available.

Ingredients

Manufacturer
Jungheon Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of pain and inflammation associated with arthritis

  • Osteoarthritis
  • degenerative arthritis
  • rheumatoid arthritis
View approved original text

Helps alleviate inflammation and pain caused by arthritic conditions such as osteoarthritis (degenerative arthritis) and rheumatoid arthritis. This medication reduces joint inflammation and eases pain, allowing patients to carry out their daily activities more comfortably. Osteoarthritis is a chronic condition caused by the wear and tear of cartilage in the joints, while rheumatoid arthritis is an inflammatory disease resulting from an autoimmune response. This medication effectively manages inflammation and pain in both conditions. Therefore, it is used to improve symptoms in patients with osteoarthritis and rheumatoid arthritis.

How to take

Adult dose

This drug is for oral use. Swallow without chewing (tablets only). ○ Adults : Administer nabumetone 1 g orally once daily at bedtime. If symptoms are severe or persistent, or worsen rapidly, administer an additional 500 mg∼1 g orally in the morning. ○ Elderly patients : As with many other drugs, plasma concentrations may be higher in elderly patients. Do not exceed a maximum of 1 g daily; in some cases, 500 mg may provide satisfactory symptom relief.

Child dose

○ Children : Clinical data on the use of this preparation in children are not yet available.

Precautions

This medication may pose a risk of gastric bleeding in individuals who regularly consume more than three drinks daily, and it is essential to consult a physician or pharmacist. Nonsteroidal anti-inflammatory drugs, including this medication, may increase the risk of severe cardiovascular diseases such as thromboembolism, myocardial infarction, and stroke, and may pose a higher risk for patients with a history of cardiovascular disease or risk factors. Additionally, this medication can cause serious gastrointestinal adverse reactions such as bleeding, ulcers, and perforation, so elderly patients and those with a history of gastrointestinal diseases should take special precautions. Patients with peptic ulcers, severe liver, kidney, or heart diseases, aspirin-induced asthma, pregnant or potentially pregnant women, children, and adolescents under 15 years of age, and patients with inflammatory bowel disease should not use this medication. Patients with blood disorders, liver dysfunction, kidney dysfunction, heart dysfunction, chronic respiratory diseases, allergic rhinitis, hypertension, and heart failure should be monitored more carefully while using this medication, and dosage adjustments or alternative treatments should be considered if necessary. This medication may cause various side effects, including allergic reactions, dyspepsia, liver dysfunction, kidney dysfunction, skin rashes, dyspnea, and blood disorders, so if any abnormal symptoms occur, medical consultation should be sought immediately. Long-term use of this medication can affect liver and kidney function, so regular blood tests and assessments of liver and kidney function are crucial. This medication may interact with other nonsteroidal anti-inflammatory drugs or specific medications, so patients should inform their physician or pharmacist of any other medications they are taking. Pregnant or breastfeeding women should not take this medication, especially in later stages of pregnancy, as it may harm the fetus. Symptoms such as dizziness or drowsiness may occur, so it is advisable to avoid driving or operating dangerous machinery. Overdose of this medication can lead to severe side effects, so it is essential to adhere to the prescribed dosage and administration, and if an overdose occurs, seek medical assistance immediately. This medication should be stored in a safe place out of reach of children and should not be transferred to another container.

Side effects

  • Shock
  • anaphylactic symptoms
  • respiratory distress
  • urticaria
  • hypotension
  • angioedema
  • facial edema
  • rash
  • itching
  • dyspepsia
Show 96 more
  • abdominal pain
  • epigastric discomfort
  • upper abdominal pain
  • abdominal distention
  • anorexia
  • nausea
  • vomiting
  • hematemesis
  • diarrhea
  • constipation
  • aerobe in the gastrointestinal tract
  • gastritis
  • peptic ulcer
  • perforation
  • gastrointestinal bleeding
  • gastrointestinal disorders
  • hematochezia
  • melena
  • ulcerative colitis
  • onset or exacerbation of Crohn's disease
  • pancreatitis
  • stomatitis
  • dry mouth
  • dizziness
  • headache
  • confusion
  • fear
  • nervous hyperactivity
  • tension
  • insomnia
  • drowsiness
  • sensory disturbances
  • elevated AST
  • elevated ALT
  • elevated AL-P
  • hepatic failure
  • hepatitis
  • jaundice
  • nephrotic syndrome
  • renal failure
  • urinary disorders
  • interstitial nephritis
  • acute tubular necrosis
  • papillary necrosis
  • increased urinary protein
  • elevated BUN
  • increased serum creatinine
  • interstitial pneumonia
  • respiratory disorders
  • bronchospasm
  • asthma
  • epistaxis
  • vascular edema
  • pseudo-Porphyria
  • hair loss
  • erythema multiforme
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • sweating
  • photosensitivity reactions
  • thrombocytopenia
  • neutropenia
  • granulocytopenia
  • leukopenia
  • leukemia
  • aplastic anemia
  • hemolytic anemia
  • vasculitis
  • hypertension
  • heart failure
  • myopathy
  • neck stiffness
  • uterine bleeding
  • menorrhagia
  • tinnitus
  • ear disorders
  • abnormal vision
  • visual disturbances
  • optic neuritis
  • edema
  • fatigue
  • asthenia
  • aseptic meningitis
  • headache
  • nausea
  • vomiting
  • gastrointestinal bleeding
  • diarrhea
  • disorientation
  • agitation
  • coma
  • tinnitus
  • fainting
  • seizures
  • acute renal failure
  • liver damage

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air ingress and kept at a temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

Yellow oval film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.